Follow

Annexin Pharmaceuticals AB

Nasdaq First North GM (Sweden)

Annexin Pharmaceuticals is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Rights issue
Price
1.25 SEK
Subscription period
20 Oct - 03 Nov 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ANNX
SE0009664154
Nasdaq First North GM
Sweden (SE)
Details of share in Annexin Pharmaceuticals AB with ticker ANNX
Status
Active
Amount of instruments
78 422 892
Currency
SEK
First trading date
19 Apr 2017
Type
Price
Pre-money
Time
Files
IPO
16.50 SEK
47.36M SEK
06 Mar - 23 Mar 2017
IPO in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Exercise
16.50-23.00 SEK
04 Dec - 15 Dec 2017
Option exercise terms for ANNX TO1
Type
Price
Pre-money
Time
Files
Rights issue
4.40 SEK
25.94M SEK
02 May - 17 May 2018
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Exercise
4.40 SEK
04 Mar - 15 Mar 2019
Option exercise terms for ANNX TO2
Type
Price
Pre-money
Time
Files
Rights issue
1.15 SEK
20.34M SEK
07 Feb - 21 Feb 2020
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Directed issue
1.951 SEK
138M SEK
25 May 2021
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Rights issue
1.25 SEK
98.03M SEK
20 Oct - 03 Nov 2021
Share issue in Annexin Pharmaceuticals AB
Type
Ticker
ISIN
Market
OPTION
ANNX TO3
Nasdaq First North GM
Sweden (SE)
Details of option in Annexin Pharmaceuticals AB with ticker ANNX TO3
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price of ten (10) trading days immediately preceding April 12, 2022, however not less than SEK 1.25 and not more than SEK 2 per share.
Type
Price
Pre-money
Time
Files
Exercise
1.25-2.00 SEK
14 Apr - 28 Apr 2022
Option exercise terms for ANNX TO3
Type
Ticker
ISIN
Market
SHARE
ANNX
SE0009664154
Nasdaq First North GM
Sweden (SE)
Details of share in Annexin Pharmaceuticals AB with ticker ANNX
Status
Active
Amount of instruments
78 422 892
Currency
SEK
First trading date
19 Apr 2017
Type
Price
Pre-money
Time
Files
IPO
16.50 SEK
47.36M SEK
06 Mar - 23 Mar 2017
IPO in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Rights issue
4.40 SEK
25.94M SEK
02 May - 17 May 2018
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Rights issue
1.15 SEK
20.34M SEK
07 Feb - 21 Feb 2020
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Directed issue
1.951 SEK
138M SEK
25 May 2021
Share issue in Annexin Pharmaceuticals AB
Type
Price
Pre-money
Time
Files
Rights issue
1.25 SEK
98.03M SEK
20 Oct - 03 Nov 2021
Share issue in Annexin Pharmaceuticals AB
Type
Ticker
ISIN
Market
OPTION
ANNX TO1
SE0009664196
Nasdaq First North GM
Sweden (SE)
Details of option in Annexin Pharmaceuticals AB with ticker ANNX TO1
Status
Archived
Amount of instruments
Currency
SEK
Trading period
19 Apr 2017 - 26 Jan 2018
Terms
Holders of warrants have the right, for each warrant, to subscribe for a new share at a subscription price corresponding to 70 percent of a volume weighted average of the trading price of the Company's shares during the period 20 November - 1 December 2017. However, the subscription price cannot be less than SEK 16.50/share or exceed SEK 23/share.
Type
Price
Pre-money
Time
Files
Exercise
16.50-23.00 SEK
04 Dec - 15 Dec 2017
Option exercise terms for ANNX TO1
Type
Ticker
ISIN
Market
OPTION
ANNX TO2
SE0011090232
Nasdaq First North GM
Sweden (SE)
Details of option in Annexin Pharmaceuticals AB with ticker ANNX TO2
Status
Archived
Amount of instruments
5 894 544
Currency
SEK
Trading period
27 Jun 2018 - 13 Mar 2019
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company.
Type
Price
Pre-money
Time
Files
Exercise
4.40 SEK
04 Mar - 15 Mar 2019
Option exercise terms for ANNX TO2
Type
Ticker
ISIN
Market
OPTION
ANNX TO3
Nasdaq First North GM
Sweden (SE)
Details of option in Annexin Pharmaceuticals AB with ticker ANNX TO3
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price of ten (10) trading days immediately preceding April 12, 2022, however not less than SEK 1.25 and not more than SEK 2 per share.
Type
Price
Pre-money
Time
Files
Exercise
1.25-2.00 SEK
14 Apr - 28 Apr 2022
Option exercise terms for ANNX TO3
People
Anders Haegerstrand
CEO
Carl-Fredrik Lindner
Chairman of the board
Johan Frostegård
Board member
Gisela Sitbon
Board member
Lena Torlegård
Board member
Company Details
Sector
HEALTH CARE

Address
Norrtullsg 6
Zip code
113 29
City/district
Stockholm
Country
Sweden (SE)
Registration number
556960-9539
LEI code
5493000JP703HGPJEX27
First trade date
19 Apr 2017
Registration date
06 Feb 2014
Short name
Annexin

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More